Literature DB >> 33160650

Mitochondria and Calcium in Alzheimer's Disease: From Cell Signaling to Neuronal Cell Death.

Maria Calvo-Rodriguez1, Brian J Bacskai2.   

Abstract

Mitochondrial dysfunction has been implicated in the pathogenesis of almost all neurological diseases, including Alzheimer's disease (AD). Historically, a primary focus in this context has been the link between mitochondrial dynamics and amyloid β toxicity. Recent evidence suggests that dysregulation of mitochondrial calcium homeostasis is also related to tau and other risk factors in AD, although an ongoing challenge in the field is that data collected from different models or experimental settings have not always been consistent. We examine recent literature on mitochondrial dysregulation in AD, with special emphasis on mitochondrial calcium. We include data from in vitro systems, genetic animal models, and AD-derived human tissue, and discuss whether mitochondrial calcium transporters should be proposed as therapeutic candidates for the development of neuroprotective drugs against AD.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  MAMs; amyloid β; calcium homeostasis; mitochondrial calcium uniporter; tau

Year:  2020        PMID: 33160650     DOI: 10.1016/j.tins.2020.10.004

Source DB:  PubMed          Journal:  Trends Neurosci        ISSN: 0166-2236            Impact factor:   13.837


  23 in total

1.  Cannabinol inhibits oxytosis/ferroptosis by directly targeting mitochondria independently of cannabinoid receptors.

Authors:  Zhibin Liang; David Soriano-Castell; Devin Kepchia; Brendan M Duggan; Antonio Currais; David Schubert; Pamela Maher
Journal:  Free Radic Biol Med       Date:  2022-01-06       Impact factor: 7.376

Review 2.  Endoplasmic Reticulum in Metaplasticity: From Information Processing to Synaptic Proteostasis.

Authors:  Shumsuzzaman Khan
Journal:  Mol Neurobiol       Date:  2022-06-23       Impact factor: 5.682

Review 3.  Altered Metabolism in Alzheimer Disease Brain: Role of Oxidative Stress.

Authors:  Nicole G Rummel; D Allan Butterfield
Journal:  Antioxid Redox Signal       Date:  2021-12-21       Impact factor: 7.468

Review 4.  Central Nervous System Pericytes Contribute to Health and Disease.

Authors:  Francesco Girolamo; Mariella Errede; Antonella Bizzoca; Daniela Virgintino; Domenico Ribatti
Journal:  Cells       Date:  2022-05-20       Impact factor: 7.666

5.  Cerebrovascular microRNA Expression Profile During Early Development of Alzheimer's Disease in a Mouse Model.

Authors:  Phoebe P Chum; Md A Hakim; Erik J Behringer
Journal:  J Alzheimers Dis       Date:  2022       Impact factor: 4.160

Review 6.  In vivo brain imaging of mitochondrial Ca2+ in neurodegenerative diseases with multiphoton microscopy.

Authors:  Maria Calvo-Rodriguez; Elizabeth K Kharitonova; Brian J Bacskai
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2021-03-05       Impact factor: 4.739

Review 7.  The role of Bcl-2 proteins in modulating neuronal Ca2+ signaling in health and in Alzheimer's disease.

Authors:  Manon Callens; Nina Kraskovskaya; Kristina Derevtsova; Wim Annaert; Geert Bultynck; Ilya Bezprozvanny; Tim Vervliet
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2021-03-09       Impact factor: 4.739

8.  Tortoise Plastron and Deer Antler Gelatin Prevents Against Neuronal Mitochondrial Dysfunction In Vitro: Implication for a Potential Therapy of Alzheimer's Disease.

Authors:  Dan Cheng; Xin-Jing Yang; Lu Zhang; Zong-Shi Qin; Wen-Qi Li; Hai-Chun Xu; Zhang-Jin Zhang
Journal:  Front Pharmacol       Date:  2021-05-13       Impact factor: 5.810

Review 9.  Recent Advances in Molecular Pathways and Therapeutic Implications Targeting Mitochondrial Dysfunction for Alzheimer's Disease.

Authors:  Rishika Dhapola; Phulen Sarma; Bikash Medhi; Ajay Prakash; Dibbanti HariKrishna Reddy
Journal:  Mol Neurobiol       Date:  2021-11-02       Impact factor: 5.682

Review 10.  Mitochondrial Ca2+ Signaling in Health, Disease and Therapy.

Authors:  Lorenzo Modesti; Alberto Danese; Veronica Angela Maria Vitto; Daniela Ramaccini; Gianluca Aguiari; Roberta Gafà; Giovanni Lanza; Carlotta Giorgi; Paolo Pinton
Journal:  Cells       Date:  2021-05-25       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.